HIGH-DOSE RADIOIMMUNOTHERAPY OF RELAPSED B-CELL LYMPHOMAS

被引：0
|
作者：
PRESS, OW
机构：
[1] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[2] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 210卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：11 / NUCL
相关论文
共 50 条
  • [21] Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue
    Hagemeister, FB
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (Suppl 1) : S13 - S20
  • [22] HIGH-DOSE CHLORAMBUCIL AND DEXAMETHASONE FOR RELAPSED NON-HODGKINS-LYMPHOMAS
    JOSEPH, G
    HADLEY, T
    DJULBEGOVIC, B
    HAMM, J
    SEEGER, J
    BLUMENREICH, M
    WOODCOCK, T
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (04): : 319 - 322
  • [23] High-dose therapy with autologous stem cell support in transformed B-cell lymphomas: a Norwegian multicentre phase II study
    Holte, H
    Lauritzsen, G
    Kvaloy, S
    Kolstad, A
    Telhaug, R
    Hammerstrom, J
    Ostenstad, B
    Maisenholder, M
    Ekanger, R
    Jacobsen, AB
    Kvalheim, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S9 - S10
  • [24] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    Aoki, T.
    Shimada, K.
    Suzuki, R.
    Izutsu, K.
    Tomita, A.
    Maeda, Y.
    Takizawa, J.
    Mitani, K.
    Igarashi, T.
    Sakai, K.
    Miyazaki, K.
    Mihara, K.
    Ohmachi, K.
    Nakamura, N.
    Takasaki, H.
    Kiyoi, H.
    Nakamura, S.
    Kinoshita, T.
    Ogura, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e372 - e372
  • [25] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    T Aoki
    K Shimada
    R Suzuki
    K Izutsu
    A Tomita
    Y Maeda
    J Takizawa
    K Mitani
    T Igarashi
    K Sakai
    K Miyazaki
    K Mihara
    K Ohmachi
    N Nakamura
    H Takasaki
    H Kiyoi
    S Nakamura
    T Kinoshita
    M Ogura
    Blood Cancer Journal, 2015, 5 : e372 - e372
  • [26] The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomas
    Hagemeister, FB
    Diehl, V
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 : 1 - 2
  • [27] High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome
    Popat, U
    Przepiork, D
    Champlin, R
    Pugh, W
    Amin, K
    Mehra, R
    Rodriguez, J
    Giralt, S
    Romaguera, J
    Rodriguez, A
    Preti, A
    Andersson, B
    Khouri, I
    Claxton, D
    de Lima, M
    Donato, M
    Anderlini, P
    Gajewski, J
    Cabanillas, F
    van Besien, K
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 63 - 69
  • [28] Successful radioimmunotherapy (RIT) of B-cell lymphomas depends on synergy between low dose rate irradiation and antibody (MAB)
    Du, Y
    Honeychurch, J
    Johnson, PWM
    Illidge, TM
    BRITISH JOURNAL OF CANCER, 2001, 85 : 59 - 59
  • [29] High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas
    Gladstone, Douglas E.
    Bolanos-Meade, Javier
    Huff, Carol Ann
    Zahurak, Marianna
    Flinn, Ian
    Borrello, Ivan
    Luznik, Leo
    Fuchs, Ephraim
    Kasamon, Yvette
    Matsui, William
    Powell, Jonathan
    Levitsky, Hyam
    Brodsky, Robert A.
    Ambinder, Richard
    Jones, Richard J.
    Swinnen, Lode J.
    LEUKEMIA & LYMPHOMA, 2011, 52 (11) : 2076 - 2081
  • [30] Role of high-dose therapy in diffuse large B-cell lymphoma
    Cerny, T
    Betticher, D
    ANNALS OF ONCOLOGY, 2000, 11 : 117 - 121
12345